|
IRGQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.143600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.437700E-02 |
| Normal-vs-Stage2 |
9.227600E-01 |
| Normal-vs-Stage3 |
5.689400E-01 |
| Normal-vs-Stage4 |
2.348100E-02 |
| Stage1-vs-Stage2 |
1.911200E-01 |
| Stage1-vs-Stage3 |
4.739600E-02 |
| Stage1-vs-Stage4 |
1.253680E-02 |
| Stage2-vs-Stage3 |
7.244600E-01 |
| Stage2-vs-Stage4 |
1.739770E-01 |
| Stage3-vs-Stage4 |
3.185200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.002200E-02 |
| Normal-vs-AfricanAmerican |
1.784590E-01 |
| Normal-vs-Asian |
8.485400E-01 |
| Caucasian-vs-AfricanAmerican |
9.658200E-01 |
| Caucasian-vs-Asian |
6.389800E-01 |
| AfricanAmerican-vs-Asian |
6.474000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.975640E-01 |
| Normal-vs-Female |
7.237400E-03 |
| Male-vs-Female |
3.730500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.351800E-01 |
| Normal-vs-Extreme_Weight |
7.713800E-01 |
| Normal-vs-Obese |
1.130080E-02 |
| Normal-vs-Extreme_Obese |
3.273000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.014000E-01 |
| Normal_Weight-vs-Obese |
8.441500E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.322600E-01 |
| Extreme_Weight-vs-Obese |
1.659750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.726400E-01 |
| Obese-vs-Extreme_Obese |
9.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.664400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.140120E-02 |
| Normal-vs-Age(61-80Yrs) |
2.742600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.727540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.197200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.724200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.138300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.081440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.522700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.216000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.81380000000054E-05 |
| Normal-VS-Type2 PRCC |
6.455600E-03 |
| Normal-VS-KIRP CIMP |
6.276400E-01 |
| Normal-VS-Unclassified PRCC |
2.323600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.22539756119977E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.199000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.637420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.411600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.583350E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.718000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.401600E-01 |
| Normal-vs-N1 |
5.973400E-01 |
| Normal-vs-N2 |
9.583800E-01 |
| N0-vs-N1 |
8.709200E-01 |
| N0-vs-N2 |
9.383800E-01 |
| N1-vs-N2 |
8.515200E-01 |
|
|
